IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 250 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,383,027 | -15.5% | 303,962 | +31.0% | 0.00% | 0.0% |
| Q2 2023 | $1,636,439 | +143321.5% | 232,119 | +25.1% | 0.00% | 0.0% |
| Q1 2023 | $1,141 | +110.5% | 185,568 | +118.8% | 0.00% | 0.0% |
| Q4 2022 | $542 | -99.9% | 84,800 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $812,000 | -30.1% | 85,179 | -20.1% | 0.00% | -50.0% |
| Q2 2022 | $1,161,000 | -18.8% | 106,600 | +24.7% | 0.00% | +100.0% |
| Q1 2022 | $1,429,000 | -8.9% | 85,512 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $1,569,000 | -33.1% | 80,788 | -18.0% | 0.00% | -66.7% |
| Q3 2021 | $2,345,000 | -42.0% | 98,559 | -35.8% | 0.00% | -50.0% |
| Q2 2021 | $4,043,000 | – | 153,549 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |